Drug Development Phase 2

Learn the factors that drive the design and conduct of phase 2 clinical trials, as well as the activities and functional areas that contribute to a successful phase 2 program.

Authors

• 

  Stephen V. O'Quinn, PharmD

  • President
  • Perissos, Inc., United States

  Stephen O’Quinn, PharmD, is the founder and President of Perissos, Inc which specializes in helping clients drive business results through insight-driven marketing and medical strategies. Stephen spent over 20 years with GlaxoSmithKline in senior leadership roles in both marketing and medical functions-- from medicines development through commercial product launch and lifecycle management. Stephen's marketing leadership roles included serving as Senior Director for 12 brands across five different therapeutic areas. Stephen holds a Doctor of Pharmacy degree, with highest honors, from the University of North Carolina at Chapel Hill.